Profound Medical Corp PRN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Profound Medical’s PRO-Talk Live! Event Features the Present and Future of TULSA
-
Profound Medical to Participate in Lake Street’s Best Ideas Growth Conference
-
Profound Medical Announces Second Quarter 2024 Financial Results
-
Profound Medical to Release Second Quarter 2024 Financial Results on August 8 – Conference Call to Follow
-
Profound Medical Announces Category 1 CPT Codes Proposed CY2025 Rule for TULSA to Treat Prostate Diseases
-
Profound Medical Shares Rise 8.7% After FDA Gives Clearance for TULSA-PRO Thermal Boost
Trading Information
- Previous Close Price
- CAD 10.76
- Day Range
- CAD 10.76–10.99
- 52-Week Range
- CAD 9.68–16.00
- Bid/Ask
- CAD 10.69 / CAD 10.82
- Market Cap
- CAD 263.67 Mil
- Volume/Avg
- 1,346 / 10,793
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 22.98
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 131
- Website
- https://www.profoundmedical.com
Comparables
Valuation
|
Metric
|
PRN
|
CLPT
|
688277
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 4.90 | 9.63 | 3.29 |
Price/Sales | 22.98 | 10.20 | 21.20 |
Price/Cash Flow | — | — | — |
Price/Earnings
PRN
CLPT
688277
Financial Strength
|
Metric
|
PRN
|
CLPT
|
688277
|
|---|---|---|---|
Quick Ratio | 7.33 | 2.18 | 2.11 |
Current Ratio | 8.61 | 2.79 | 2.75 |
Interest Coverage | — | — | −15.62 |
Quick Ratio
PRN
CLPT
688277
Profitability
|
Metric
|
PRN
|
CLPT
|
688277
|
|---|---|---|---|
Return on Assets (Normalized) | −47.26% | −24.04% | −13.35% |
Return on Equity (Normalized) | −61.34% | −41.45% | −17.03% |
Return on Invested Capital (Normalized) | −59.56% | −29.10% | −14.15% |
Return on Assets
PRN
CLPT
688277
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Cmgypcst | Brzxx | $198.4 Bil | |||
| Stryker Corp
SYK
| Gmprcrfh | Blxc | $137.7 Bil | |||
| Boston Scientific Corp
BSX
| Rjjwynbk | Yklwh | $123.4 Bil | |||
| Medtronic PLC
MDT
| Wpsmvjxn | Wzrdg | $115.5 Bil | |||
| Edwards Lifesciences Corp
EW
| Qkxbfwmlq | Ltdsyy | $39.8 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Gkqc | Bmvy | $30.6 Bil | |||
| DexCom Inc
DXCM
| Bdknghdmvz | Pwfj | $26.9 Bil | |||
| Steris PLC
STE
| Fbxsjwzt | Mgvxkbl | $23.9 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Trspblhrj | Tlb | $22.0 Bil | |||
| Insulet Corp
PODD
| Qbqwcyvdm | Tscvfyt | $16.3 Bil |
United States